Medtronic plc.

MDT is set to recover - overreaction on the outlook

69
MDT beat analysts' estimates but guided somewhat dovish. The market has penalized the stock - it could be an overreaction. The management executes well on the business. I expect higher prices.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.